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90Sr appears as a radionuclide in the decay series of nuclear fission and can therefore be found in nuclear waste
or released by nuclear accidents. Current methods for the detection of this radionuclide are time consuming
and may be prone to a large variety of interferents. In this work, inductively coupled plasma mass spectrometry
is explored for the determination of 90Sr in the presence of stable zirconium in urine. Specific techniques are
investigated to remove this as well as other contributions to the background at m/z ~ 90. A quadrupole ICP-
MS equipped with a hexapole collision cell is first explored (final LOD ~ 2 ng L21 for water samples),
however, the desired limit of detection for 90Sr in urine is quite low (0.02 pg L21). The performance of a
double-focusing sector field ICP mass spectrometer (ICP-SFMS) is further investigated, which allows
measurement of 90Sr at the ultratrace level. Other potential interferences were investigated and instrumental
detection limits are calculated as 3 pg L21 for water samples. Final parameters include the use of a cool plasma
and medium mass resolution in ICP-SFMS. The method is applied to the analysis of 90Sr extracted from urine
using a crown ether extraction resin and concentrated (enrichment factor: 200); high levels of natural strontium
in the separated fraction (of about 1 mg mL21) equate to higher detection limits (80 pg L21) due to 88Sr1
at m/z ~ 90 and the relatively low abundance sensitivity of ICP-SFMS at medium mass resolution of
6 6 1027. This detection limit in the separated fraction corresponds to the detection limit of 0.4 pg L21 in the
original urine sample. The recovery of 90Sr, determined with the developed analytical method in spiked urine
samples, was in the range of 82–86%.
Introduction
90Sr is a by-product of the nuclear fission of uranium and
plutonium in nuclear reactors and in nuclear weapons. It is a
major radionuclide in spent nuclear fuel and radioactive waste
and it is considered one of the more hazardous constituents of
nuclear wastes. Large amounts of 90Sr were produced during
atmospheric nuclear weapons tests of the 1950s and 1960s
and dispersed worldwide. Additionally, the accident at the
Chernobyl nuclear power plant introduced a great amount of
90Sr into the environment and a large part of the 90Sr was
deposited in the Soviet Republics. The rest was dispersed as
fallout over Northern Europe and worldwide. As this radio-
nuclide decays, it releases radiation and forms 90Y, which in
turn decays to stable zirconium (90Zr). 90Sr (T1/2~ 29.1 years)
emits moderate energy beta particles, and 90Y (T1/2 ~ 64 h)
emits very strong (energetic) beta particles.
Radioactive strontium is of interest because of its impact in
both environmental and health areas. Deposition mainly
occurs with rain or other precipitation and strontium is very
accessible to plants via soil uptake mechanisms.1 90Sr is also
very significant with regard to health concerns as it is efficiently
transferred to humans through the food chain. It is taken up via
the gastrointestinal tract and behaves chemically much like
calcium, and therefore tends to concentrate in the bones and
teeth. When people ingest 90Sr, about 70–80% of it passes
through the body and urine therefore presents an attractive
medium by which to measure exposure. Virtually all of the
remaining 20–30% that is absorbed is deposited in the bone.
About 1% is distributed among the blood volume, extracellular
fluid, soft tissue and surface of the bone, where it may stay and
decay or be excreted.2 The radiation affects the production of
new blood cells, which eventually leads to death. Furthermore,
internal exposure to 90Sr is linked to bone cancer, cancer of the
soft tissue near the bone, and leukemia.2
Radiochemical analysis techniques are typically used for the
determination of 90Sr and may yield method detection limits as
low as 0.02 pg L21 after sample concentration.3 These methods
require the isolation of 90Sr so as to eliminate interference
from other radioactive species. Isolation of 90Sr from the
radioactive isotopes of lead, polonium, plutonium, neptunium
and potassium has proved difficult with current extraction
techniques.4 Furthermore, the liquid scintillation techniques
that may be used for detection present a challenge in the
analysis of 90Sr in the presence of 90Y. Spectra of both
radionuclides overlap in a certain zone and this may be
resolved by mathematical calculations of 90Y ingrowth or by
simply waiting for radiochemical equilibrium to be reached
(2–3 weeks). Monitoring the effluent of nuclear power plants is
a continuous process and readily available, faster analysis times
may prove favorable.5
In the event of an atomic accident, an even more rapid,
efficient and reproducible method is needed. Some have
investigated the inductively coupled plasma-mass spectrometer
(ICP-MS) because of its selectivity, sensitivity and accuracy in
the detection of different radioactive isotopes.6–8 The newly
developed ICP-MS methods have been found to possess higher
sensitivity and greater efficiency and may replace many of the
radiometric techniques.9 Furthermore, they are not encum-
bered with the uncertainty of removing all other beta-emitting
nuclides from the sample. ICP-MS is therefore investigated for
detection of radioactive strontium and potential interferents in
this type of analysis are addressed. Sensitivity and selectivity
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Experimental
Instrumentation
A double-focusing sector field ICP-MS instrument (ELE-
MENT, ThermoFinnigan, Bremen, Germany) was used in this
study. A grounded platinum electrode GuardElectrode2 (GE)
from Finnigan-MAT, was inserted between the quartz ICP
torch and rf load coil. Solution introduction into the ICP was
performed by a Micromist nebulizer (Glass Expansion,
Romainmotier, Switzerland) with a Scott double-pass quartz
spray chamber cooled to 4 uC.
The second instrument employed was a quadrupole-based
ICP-MS with a hexapole collision cell (Platform, Micromass
Ltd., Manchester, UK). Oxygen was introduced into the
collision cell of the ICP-CC-MS as a collision and reaction gas.
For solution introduction into the instrument, a Meinhard
nebulizer (J.E. Meinhard Associates, Inc, Santa Ana, CA,
USA) with a Scott double-pass quartz spray chamber cooled to
4 uC was used. Aqueous solutions were introduced in the
continuous flow mode via a peristaltic pump (Perimax 12,
Spetec GmbH, Erding, Germany). Specific instrument operat-
ing conditions for both instruments are shown in Table 1.
Nebulization
All experiments were performed solely with the Meinhard
nebulizer with the ICP-CC-MS and the Micromist nebulizer
with the ICP-SFMS. Others have noted an order of magnitude
improvement with the use of an ultrasonic nebulizer (USN)10–12 as
only the dry aerosol is introduced into the plasma. However, its
typical uptake rate is 1 mL min21 and the dose to the operator
as well as contamination of the instrument were considered
critical issues in the analysis of this radionuclide.13
Reagents and standards
All water was deionized (18 MV cm) and was obtained from a
Millipore Milli-Q-Plus water purifier. Commercial chemicals
were analytical reagent grade and were used without further
purification. Solutions were acidified with sub-boiled nitric
acid. Specific reagents used in the sample preparation
procedure are discussed in the section below.
Sample preparation
Extraction chromatography is a particular form of liquid–
liquid column chromatography in which the stationary phase is
constituted by an organic extractant held on a supporting
surface and the mobile phase is an inorganic solution, usually
an acid. For example, Gjeci14 and Alvarez3,15 both utilized
specific crown ether stationary phases that selectively enacted
the retention of Sr. The resin consists of an octanol solution of
4,4’(5’)-bis(t-butylcyclohexano)-18-crown-6 sorbed on an inert
polymeric support and is commercially available under the
trade name Sr.Spec. The extraction chromatography resin used
in this work was obtained as pre-packaged 2 mL columns from
Eichrom Industries (Darien, Illinois, USA). Note, the uptake
of Sr by this resin increases with increasing nitric acid
concentration. At 8 M nitric acid, k’ is approximately 90 and
it falls to less than 1 at concentrations of nitric acid less than
0.5 M.
After acidification with 60 mL of concentrated HNO3, urine
samples were heated at 70–80u and stirred constantly with a
magnetic stir plate. A volume of 1 mL of concentrated H3PO4
and a volume of 2 mL of a 40 mg L21 Ca(NO3)2 (as calcium)
were added and the sample was heated at this constant
temperature for ½ hour. Concentrated ammonia was added
until the calcium phosphate appeared (which would be carrying
the strontium). The sample was then heated for one hour and
the resulting solution was centrifuged. The supernatant was
decanted and the residue was dissolved in 10 mL of 8MHNO3.
This 10 mL volume then was passed through the Sr column.
Prior to this, columns were washed with 25 ml of 0.05 MHNO3
to elute residual Sr from the resin. A vacuum manifold was
used to facilitate the passage of the sample through the resin.
The strontium remained on the resin of the column and was
then eluted with a 5 mL volume of 0.05 M HNO3.
Results and discussion
Isobaric interferences of atomic ions
The use of sector field ICP-MS or ICP-MS with a collision cell
eliminates many of the interferences encountered with radio-
chemical detection and both have been found to be selective
and sensitive means by which to measure various elements.
However, difficulties may arise with isobaric interferences of
atomic ions or molecular ions that result from the matrix of the
sample or the plasma itself. The most critical issue is the
appearance of radioactive and stable nuclides at the same mass
with a different atomic number. All interferences must be
considered and eliminated to obtain accurate and sensitive
analysis of radioactive strontium at m/z ~ 90.
90Y is the first decay product of 90Sr decay. Although yttrium
may be removed by the use of strontium-specific resins, once
the procedure is completed 90Y will be produced by the decay
of 90Sr. This is of concern when using radiochemical detection
techniques16 as they are very sensitive. Therefore, when using
these types of detection, the samples are not analyzed until an
equilibrium is reached (2–3 weeks). Alternatively, mathema-
tical correction formulae may be employed. As described later
in this paper, detection limits of 90Sr are quite low. Therefore,
because the 90Y/90Sr concentration ratio will be 0.025% in the
activity equilibrium, ICP-MS will not be sensitive enough to
detect the yttrium ingrowth that would be expected from
typical levels of 90Sr.
90Zr1 represents a second isobaric interference and its
removal may be accomplished by several means. Again, it may
Table 1 Experimental conditions
ICP-CC-MS parameters
Forward power 750 W
Coolant gas flow rate 13.5 L min21
Auxiliary gas flow rate 1.0 L min21
Nebulizer gas flow rate 0.8 L min21
Solution uptake rate 0.9 mL min21
Sampling and skimmer cones Nickel
Dwell time 0.2 s per isotope
Extraction lens (cone) potential 2600 V
Transfer lens (hexapole exit)
potential
2400 V
Hexapole bias potential 20.8 V




Spray chamber Scott double-pass
Cell gas O2
Flow rate of cell gas 1.9 mL min21
ICP-SFMS parameters
Forward power 750 W (with guard electrode)
Coolant gas flow rate 14 L min21
Auxiliary gas flow rate 0.8 L min21
Nebulizer gas flow rate 1.04 L min21
Solution uptake rate 0.3 mL min21
Sampling and skimmer cones Nickel
Dwell time 0.2 s per isotope
Extraction lens potential 22000 V
Focus lens potential 21000 V
Nebulizer Micromist
Spray chamber Cinnabar low volume cyclonic
Mass resolution 4450
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be possible for the separation to be specifically conducted prior
to analysis.17 However, the current techniques utilized for
strontium isolation prior to measurement, such as precipita-
tion, ion exchange or solvent extraction,18,19 are not considered
selective or safe and, additionally, may require large amounts
of resins/acids and solvents as well as time. A new advance in
the isolation of radioactive strontium has been the use of
extraction chromatography. Although this preparation tech-
nique may serve to eliminate some of the zirconium, others
have noted that similar resins may not completely remove all
interferents of interest.20
Instrumental techniques used for interference elimination
may include the utilization of a sector field ICP mass
spectrometer at its maximum mass resolution (m/Dm) of
12 000, the application of a collision cell or a cool plasma in
ICP-MS.21 A sector field ICP-MS can be used to accomplish
mass measurements at required mass resolution and sub-
sequently, it may be possible to separate interferences from the
isotopes of interest.22 However, it is generally not possible to
separate isobaric singly charged atomic ions, such as 90Sr1
from 90Zr1, due to the low mass difference (mass of 90Sr ~
89.9077 u and 90Zr ~ 89.9047 u) using commercial ICP mass
spectrometers, because a mass resolution of approximately
30 000 would be necessary for their separation.
A possible way to solve the interference problem is the
application of ICP-MS with a collision cell as unwanted ions
produced in the plasma can be selectively removed or shifted in
m/z ratio prior to mass spectral analysis by the addition of
specific reagent gases.23 In studies of ion/molecule reactions
performed by Eiden et al., it was shown that Y and Zr react
with O2 over two orders of magnitude faster than Sr.
24 Further
research showed that Sr1 was not reactive with the chosen
reaction gas, O2, and a stronger oxidant, nitrous oxide, was
needed to form strontium oxide with the purpose of separating
it from same mass Rb.25
Initial experiments in this laboratory using a collision cell
pressurized with O2 were successful. Strontium was monitored
at m/z 88 and zirconium at m/z 90. A flow rate of 1.9 mL min21
O2 was sufficient to promote the oxide ion formation of
zirconium, as can be seen in Fig. 1. With increasing O2 gas flow
rate, the 90Zr1 intensity decreases. The zirconium isotope at
m/z 90 is oxidized and therefore will be observed as 90ZrO1 at
m/z 106. Additionally, scattering losses were offset by initial
collisional focusing, hence the strontium signal was unaffected
overall. The calculated limit of detection for strontium was
2 ng L21 with ICP-CC-MS, primarily due to the relatively high
background count rate of the Daly-type detector in the ICP-
CC-MS sytem.26 Detection limits are defined as the equivalent
concentration of three times the standard deviation of the
blank response. The standard deviation was calculated from six
consecutive measurements of the blank solution at m/z ~ 90.
Unfortunately, this instrumental configuration did not meet
the desired limit of detection, which is 0.1 Bq L21. This unit of
activity is directly proportional to the half-life when converting
it to a unit of concentration:
N ~ (A/ln2) 6 T1/2
Therefore, if N represents the number of atoms, an activity,
A, of 0.1 Bq L21 translates to 0.02 pg L21. Current sample
preparation procedures for radioactive strontium (extraction
chromatography, discussed earlier) possess an effective con-
centration factor of 200 (yielding a desired limit of detection for
the method of 4 pg L21).
Another alternative to the collision cell in the removal of
interferences is the use of a cool plasma: this is a plasma which
works at lower forward powers in an effort to suppress
ionization of elements of higher ionization potential. The
ionization potentials of strontium and zirconium are 5.7 eV and
6.8 eV, respectively, therefore Zr1 could theoretically be
suppressed under cool plasma conditions. Forward power was
varied and plotted against ion intensity of the elements of
interest; other instrument parameters were held constant. In a
second experiment, oxygen was added to the plasma at varying
percentages of the flow rate of the argon nebulizer gas. Others
have noted that when argon and oxygen are used for the
nebulizer gas, cool plasma conditions are achieved.27 Results of
both experiments on the quadrupole instrument can be seen in
Fig. 2. It is unclear whether the similar results in the second
graph are due to the application of this cool argon–oxygen
plasma or whether this is due to some oxide formation, as seen
by others,28 and it may be a combination of both phenomena.
However, this speculation could not be verified due to the high
background at m/z ~ 106. Becker and Dietze noted a general
increase in the oxide formation rate of other radionuclides with
the use of a shielded torch under hot plasma conditions10 and
others have noted that the strong bonds of oxides usually
withstand plasma conditions.21 The calculated detection limits
(3s; blank Milli-Q water) can be found in Table 2 and again
these were not found to be adequate for the analysis of 90Sr in
urine.
Sector field mass spectrometers utilizing an ICP ionization
source are used widely in the area of elemental and isotopic
Fig. 1 Response of 88Sr1 and 90Zr1 with increasing flow rate of O2 in
the collision cell. Both elements are at a concentration of 50 mg L21.
Fig. 2 Effect of rf power (A) and percentage of O2 in nebulizer gas (B)
on the response of 88Sr1 and 90Zr1 with the ICP-CC-MS. Strontium
concentration is 50 mg L21 and zirconium is 1000 mg L21.
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analysis, and especially in the determination of long-lived
radionuclides,29 because of two distinct advantages with regard
to resolution and sensitivity.30,31 Fig. 3 shows the results
obtained using a cool plasma and the ICP-SFMS with the
shield torch. The concentration of Sr was 100 ppt and of Zr was
5 ppb; the concentration of natural zirconium in urine may be
approximately 25 ppt and this translates to as much as 5 ppb in
the final extract (assuming a 200-fold enrichment factor
resulting from the sample preparation process). The first
graph of Fig. 3 shows the results of varying the rf power after
tuning the instrument at 1350 W. In the second graph of the
figure, the nebulizer gas flow rate and the ion focus lens were
adjusted to maximize the 88Sr1 intensity while minimizing that
of 90Zr1 at a forward power of 750 W.32 This equated to a
nebulizer gas flow rate of 1.04 L min21 (versus 0.88 L min21
under hot plasma conditions) and ion focus lens voltage of
21000 V (versus 2855 V under hot plasma conditions). Both
graphs show a lower effect for Sr1 compared with the collision
cell instrument. This may be due to the additional focusing that
occurs with the hexapole of the quadrupole instrument as the
cell is still pressurized with gases from the plasma even when
not purposely in use. Also, the interaction time of the ions with
oxygen will be significantly longer in ICP-CC-MS without
collision gases due to the lower kinetic energy of the ions and
relatively long ion trajectories in the hexapole, compared with
other instruments. Calculated detection limits are given in
Table 3.
Oxygen was also added to the nebulizer gas of the sector field
instrument to effect the formation of a cool plasma as described
above. Intensity of 88Sr1 and 90Zr1 as a function of the
percentage of oxygen in the nebulizer gas is shown in Fig. 4.
The voltage of the focus lens was optimized with the addition of
50% oxygen in the nebulizer gas and the calculated detection
limit for strontium was 13 pg L21. Further experiments were
conducted solely with an rf power of 750 W as this setting
demonstrated acceptable limits of detection in addition to the
fact that a cool plasma generated from lowering the rf power
only requires slight modification of existing instrumentation
without any additional high-purity gases.
Polyatomic interferences
There exists the potential for ion formation of argon–carbon
based interferences such as 38Ar40Ar12C1. Generally, cool
plasma conditions inhibit the formation of argon-based
polyatomic ions.33 In work published by Vanhaecke et al.,
an rf power of 750 W was applied and this was sufficient to
reduce the formation of the 40Ar12C1 diatomic ion that
interfered with the determination of the major chromium
isotope at m/z ~ 52.34 The formation of 38Ar40Ar12C1 was
investigated through the introduction of a solution of 0.01%
trichloroacetic acid under the optimized conditions and with a
cool plasma. An increase in background at m/z ~ 90 was not
observed in this experiment. Other potentially less prevalent
argon-based diatomic ions, such 38Ar52Cr1, 36Ar54Fe1,
40Ar50Ti1 and 40Ar50Cr1, were also investigated by analysis
of solutions containing the respective elements; again, no
increase in the background at m/z ~ 90 was observed under
established conditions.
Table 2 Limits of detection for ICP-CC-MS in water samples








1.9 ml min21 O2 1350 3
900 2
750 5
0.9 ml min21 O2 900 3
1350 40 2
Fig. 3 Effect of rf power on the response of 88Sr1 and 90Zr1 with the
ICP-SFMS. A~Nebulizer gas flow rate of 0.88 L min21 and ion focus
lens voltage of 2855 V. B ~ Nebulizer gas flow rate of 1.04 L min21
and ion focus lens voltage of 21000 V.
Table 3 Limits of detection for ICP-SFMS in water samples
rf power Resolution O2 in nebulizer gas/% Limit of detection/ng L
21
750 (lens and nebulizer gas tuned at 1350 W) Low 0.017
750 (lens and nebulizer gas tuned for cold plasma) Low 0.004
750 (lens and nebulizer gas tuned at 1350 W) Medium 0.005
750 (lens and nebulizer gas tuned for cold plasma) Medium 0.003
1350 W (50% O2 in nebulizer gas) Low 50 0.013
Fig. 4 Effect of percentage of O2 in nebulizer gas on the response of
88Sr1 and 90Zr1 with the ICP-SFMS.
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A second potential contribution to the background at m/z~
90 is the formation of nickel-based interferences, such as
58Ni16O2
1 or 60Ni16O14N1, due to the use of nickel extraction
cones. This was more prevalent when O2 was added in
sequential percentages to the nebulizer gas of the ICP-CC-MS
instrument, as can be seen in Fig. 5. With the addition of
oxygen, the interferent at m/z~ 90 increases by approximately
one order of magnitude. Interestingly, there is no change in the
abundance of the interferent at m/z~ 92, as would be expected
due to 60Ni16O2
1, and this may be due to the elimination of the
carbon-based interference under the cooler plasma generated
with the addition of oxygen. With the sector field instrument, a
medium resolution setting (m/Dm ~ 4450) was adequate to
separate these nickel-based polyatomics and therefore elimi-
nate all background at m/z ~ 90. The limit of detection
obtained with this resolution setting is given in Table 3 and is
comparable to the reported detection limit found by other
workrers of 7 ppq for 88Sr with a USN coupled to an ICP-
SFMS with hot plasma and no shield torch.11
A third possible contribution to the background at m/z~ 90
is the hydride ion formation of stable 89Y, although if
extraction chromatography is used for sample preparation,
yttrium removal is expected. A solution containing only
yttrium at a concentration of 200 ppb was prepared and
analyzed in conjunction with a nitric acid blank. The
background at m/z ~ 90 was examined for hydride formation
and no such phenomenon was observed.
Abundance sensitivity
In all magnetic sector mass spectrometers, there is a small
contribution to peak intensity from adjacent peaks.35 This
abundance sensitivity of sector field instruments is less than
that of quadrupole instruments.36 The average concentration
of stable strontium in urine was experimentally determined to
be approximately 5 mg L21; abundance sensitivity was studied
at medium mass resolution (m/Dm ~ 4450) using a standard
solution with concentration of 1 mg mL21 of strontium. In
order to correct for possible interferences, intensity was
measured at the masses m ¡ 0.5 u, m ¡ 1.5 u, m ¡ 2.5 u,
etc. Abundance sensitivity was calculated as the intensity at
m/z ~ 90/intensity at m/z ~ 8826 and in medium mass
resolutionmodewas found to be 66 1027 (26 1025 in lowmass
resolution mode). Additionally, peak-tailing can be reduced
further by applying a higher mass resolution and abundance
sensitivity was measured at 4 6 1027 at m/Dm ~ 12 000, but
this was accompanied by a decrease in the intensity of the
analyte ions.
90Sr determination in real urine samples
In this work, urine samples were prepared as outlined in the
Experimental section. As stated previously, the sample
preparation procedure represented an effective sample con-
centration factor of 200. Additionally, as described earlier,
natural levels of strontium in urine were experimentally
determined to be in the range of 5 ppb. Taking into account
these two facts results in a final extract with a concentration of
approximately 1 ppm of natural strontium. Medium mass
resolution would therefore not be capable of removing all
counts at m/z ~ 90 due to the peak tail of 88Sr1 and
this was shown experimentally. The background at m/z ~ 90
was increased by approximately two orders of magnitude.
Correction was performed: however, this served to decrease the
precision of the measurements and therefore detection limits
would be expected to increase.
The method detection limit was calculated as three times the
standard deviation of the intensity signal on m/z 90, measured
on six independently prepared procedural blanks. The increase
as compared with the instrumental detection limit amounted to
20-fold, as can be seen in Table 4. The resulting method
detection limit for concentrated urine solution was 80 pg L21,
which corresponds to the 0.4 pg L21 in the original urine
sample. For all investigated urine samples, the concentration of
90Sr was below the method detection limit of 0.4 pg L21.
A final point worthy of note concerns the inherently high
levels of natural strontium contained within the extractions
resins. Although this would not be problematic with the use of
radiochemical analysis schemes, with ICP-MS these high levels
serve to increase the background at m/z ~ 90 and hence the
limit of detection. Three washes of the extraction resin with
0.05 M HNO3 was found to be sufficient to remove all natural
Sr from extraction resin, as shown in Fig. 6.
In a final evaluation of the sample preparation procedure,
Fig. 5 Effect of oxygen in the nebulizer gas on the background at m/z
~ 90 with the ICP-CC-MS instrument.
Table 4 Figures of merit in calculation of limit of detection of 90Sr in urine
Prepared urine sample (concentration factor of 200)
Natural Sr concentration in analyte solution after enrichment y1 mg L21
Ion intensity of 88Sr1 3.8 6 107 cps
Abundance sensitivity (medium resolution) 6.0 6 1027
Average background counts at m/z ~ 90 29
Average corrected background counts at m/z ~ 90 5.2 (average sd ~ 1.1)
Limit of detection (concentration) 80 pg L21 (0.4 pg L21in original urine samples)
Limit of detection (activity) 400 Bq L21 (2 Bq L21in original urine samples)
Fig. 6 Washing of Sr from Sr-resin prior to use in separation
procedure.
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the capacity of the extraction resin with respect to the high
concentration of 88Sr in urine was assessed. Additional analyses
of urine samples spiked with 1 ng L21 and 5 ng L21 of 90Sr were
conducted. The recovery of 90Sr, determined with the
developed analytical method, was in the range of 82–86%.
Conclusion
Although a collision cell pressurized with oxygen was able to
remove ions that would interfere in the measurement of 90Sr,
issues specific to the analysis of radionuclides, such as the low
limit of detection in Bq L21 as well as natural strontium
concentrations in pertinent samples, were not considered in
work done by others.24,25 The need for an instrument of high
sensitivity was shown and a sector field inductively coupled
plasma mass spectrometer was applied to the analysis of
radioactive strontium in urine. The isobaric interference of
zirconium was removed by a cool plasma operated at
750 W. Argon-based polyatomic ions did not interfere at
m/z ~ 90 as their formation was prohibited in the low power
plasma. A medium mass resolution setting proved adequate in
the separation of nickel-based interferents, such as 58Ni16O2
1,
resulting from use of nickel sampler and skimmer cones.
Additionally, the formation of YH1 did not occur under
ultimate operating conditions and a final instrument detection
limit of 3 pg L21 was reported for water samples. However, the
abundance sensitivity of the ICP-SFMS in medium mass
resolution (6.0 6 1027) was not adequate with regard to the
natural levels of strontium in urine. The limit of detection
after sample concentration of this matrix was increased about
20-fold. Future work should extend to the application of a
mass spectrometer with better abundance sensitivity. Although
thermal ionization mass spectrometry has shown an abundance
sensitivity of 1.2 6 10210 in the measurement of 236U,37 and
others have shown equally good abundance sensitivity with
resonance ionization mass spectrometry for the measurement
of 90Sr,38 ICP-MS has been shown to be more suitable for
routine measurement with regard to sample preparation and
quantification procedures.39 Furthermore, reported figures of
merit for both abundance sensitivity (better than 1028 for 90Sr)
as well as sensitivity with a multicollector ICP-MS40 should
allow the detection of 90Sr at low fg L21 levels (in original
sample) in samples high in natural strontium.
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